An 88 year-old-doctor from Edwards, Mississippi is on the brink of losing his license to practice medicine. Dr. Carroll Landrum’s license is at risk because the doctor practices out of his 2007 Toyota Camry. The Clarion-Ledger recently reported on the doctor’s mobile medical practice.
Dr. Landrum is the only practicing doctor in Edwards, a town with just over a thousand residents. He parks his car and visits with patients in the parking lot of an ...
continue reading...
The United States Food and Drug Administration (FDA) has recently announced efforts to improve pharmaceutical quality and to establish an Office of Pharmaceutical Quality. A recent Reuters’ article looks at the FDA’s push to address lapses in quality control by pharmaceutical manufacturers, saying “the FDA has only had a general sense of the state of manufacturing quality at the country’s drugmakers.” According to the story, the FDA aims to have full quantitative information. The new ...
In a recent announcement from the U.S. Department of Justice, a whistle-blower lawsuit against the major pharmaceutical company Shire resulted in a $56.5 million settlement. An article in First Word Pharma reports that the Shire CEO is “pleased to have reached a resolution” over the improper marketing of a number of its drugs.
The lawsuit claims that the company “violated the False Claims Act by improperly marketing and promoting several drugs.” The claim alleged ...
continue reading...
An investigation by the Michigan Department of Community Health’s Office of Recipient Rights alleges that a former director of a Michigan hospital did not properly report that death of a patient in March, 2014 that may have involved negligence.
In May, a nurse, a nursing director, and the director of the Kalamazoo Psychiatric Hospital were all suspended, based on multiple complaints about patient treatment. One of the complaints involved the death of a 68 year ...
continue reading...
The number of Lipitor lawsuits against the pharmaceutical company Pfizer continues to grow. A story in Reuters explains the rising number of diabetes lawsuits that allege the anti-cholesterol drug has caused serious health complications in women. The number of lawsuits filed over the past five months in federal court has gone from 56 to almost 1,000.
In 2012 the FDA issued a warning that statins such as Lipitor have been linked to an increase in blood ...
continue reading...
First Word Pharma reports that Androgel maker AbbVie has abandoned its plan to buy out pharmaceutical maker Shire. AbbVie says the bid for Shire was withdrawn in light of recent U.S. tax law changes. As a result of the failed deal, AbbVie will have to pay $1.6 billion to Shire and will be unable to make another offer to purchase the company for at least a year.
The Androgel maker was recently in the news over ...
continue reading...
